Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL19732617 | 0.98 | CYP2C19 (0.44) | CYP2C19EGFRERBB2CNR2ALDH1A1 | |
| SCHEMBL21065748 | 0.98 | CYP2C19 (0.44) | CYP2C19EGFRERBB2CNR2ALDH1A1 | |
| SCHEMBL17660030 | 0.96 | EGFR (0.42) | CYP2C19EGFRERBB2CNR2ALDH1A1 | |
| SCHEMBL17660035 | 0.96 | EGFR (0.42) | CYP2C19EGFRERBB2CNR2ALDH1A1 | |
| SCHEMBL21242480 | 0.96 | CNR2 (0.48) | CYP2C19EGFRERBB2CNR2ALDH1A1 | |
| SCHEMBL17660036 | 0.96 | EGFR (0.42) | CYP2C19EGFRERBB2CNR2ALDH1A1 | |
| SCHEMBL15682788 | 0.96 | EGFR (0.42) | CYP2C19EGFRERBB2CNR2ALDH1A1 | |
| SCHEMBL2493461 | 0.94 | EGFR (0.41) | CYP2C19EGFRERBB2CNR2ALDH1A1 | |
| SCHEMBL11313427 | 0.93 | CNR2 (0.49) | CYP2C19EGFRERBB2CNR2ALDH1A1 | |
| SCHEMBL22321042 | 0.91 | CNR2 (0.51) | CYP2C19CNR2ALDH1A1TSHRKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 387 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1858995-B1 | RADICALLY CURABLE COATING COMPOUNDS | BASF SE (DE) | 2009-03-04 | — | — | EP | claimed |
| US-20080160320-A1 | Radically Curable Coating Compounds | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-03 | — | — | US | claimed |
| US-6512068-B1 | Substantially transparent adhesive composition for hard tissue, and a method for producing it; the adhesive composition exhibits good adhesiveness to hard tissue, especially to both enamel and dentin, and has the advantage of | KURARAY CO., LTD. (JP) | 2003-01-28 | — | — | US | claimed |
| US-4360621-A | FOR RUBBERS AND POLYURETHANES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-11-23 | — | — | US | claimed |
| US-4069242-A | SYNERGISTIC CATALYST SYSTEM CONTAINING AMMONIUM OR AMINE NITROGEN AND IRON OR CHROMIUM COMPOUND | THE DOW CHEMICAL COMPANY (US) | 1978-01-17 | — | — | US | claimed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| US-12077631-B2 | Bulk polymerisation of polyoxazolidone | BASF SE (DE) | 2024-09-03 | — | — | US | disclosed |
| US-20240116965-A1 | ORGANOMETALLIC COMPOUNDS | UMICORE AG & CO. KG (DE) | 2024-04-11 | — | — | US | disclosed |
| US-20230384496-A1 | OPTICAL MEMBER FOR USE IN DISPLAY DEVICE AND DISPLAY DEVICE INCLUDING DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-11-30 | — | — | US | disclosed |
| EP-4267591-A2 | ORGANOMETALLIC COMPOUNDS | Umicore AG & Co. KG (DE) | 2023-11-01 | — | — | EP | disclosed |
| US-11789307-B2 | Colorant filter, backlight unit, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2023-10-17 | — | — | US | disclosed |
| CN-116802187-A | Organometallic compounds | 优米科尔股份公司及两合公司 | 2023-09-22 | — | — | CN | disclosed |
| US-5028734-A | Process for the selective preparation of alkenecarboxylic acid derivatives | SHELL OIL COMPANY (US) | 1991-07-02 | — | — | US | disclosed |
| US-5026901-A | Producing alkyl pentenoate | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-06-25 | — | — | US | disclosed |
| US-4824817-A | Catalyst for the carbonylation of conjugated dienes | SHELL OIL COMPANY (US) | 1989-04-25 | — | — | US | disclosed |
| EP-0273489-A2 | Process for the selective preparation of alkenecarboxylic acid derivatives | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-07-06 | — | — | EP | disclosed |
| US-4360621-A | FOR RUBBERS AND POLYURETHANES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-11-23 | — | — | US | disclosed |
| US-4172087-A | COORDINATION CATALYSTS CONTAINING PALLADIUM | TEXACO DEVELOPMENT CORPORATION (US) | 1979-10-23 | — | — | US | disclosed |
| US-4124617-A | CATALYST COMPRISING PALLADIUM SALTS COMBINED WITH TERTIARY PHOSPHORUS CONTAINING LIGANDS | TEXACO DEVELOPMENT CORPORATION (US) | 1978-11-07 | — | — | US | disclosed |
| US-4069242-A | SYNERGISTIC CATALYST SYSTEM CONTAINING AMMONIUM OR AMINE NITROGEN AND IRON OR CHROMIUM COMPOUND | THE DOW CHEMICAL COMPANY (US) | 1978-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116965-A1 | ORGANOMETALLIC COMPOUNDS | DDT, PPOX, PDCD2L | CYP2C19 1003/4885EGFR 3578/4885ERBB2 2637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.